CD8A and cancer: ELANE exerts its anti-tumor effects by promoting the apoptosis of cancer cells, while simultaneously increasing the presence of tumor dendritic cells (DCs), CD8+ T cells, and CD8+ T effector cells (CD8+ Teffs) [50].